CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Rene Kahn

OPENALEX: A5031613969↗ORCID: 0000-0001-5909-8004↗

Affiliations

Organizations

Heidelberg Universityauthorship · DE Icahn School of Medicine at Mount Sinaiauthorship · US Tergooiauthorship · NL University Hospital Heidelbergauthorship · DE University Medical Center Utrechtauthorship · NL University of Amsterdamauthorship · NL Utrecht Universityauthorship · NL

Public evidence

3 connected articles

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample.2025 · Europe PMC Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium.2016 · PubMed Central Open Access Evidence That Transition from Health to Psychotic Disorder Can Be Traced to Semi-Ubiquitous Environmental Effects Operating against Background Genetic Risk2013 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Rene Kahn - Medical Cannabis Research Engine